Literature DB >> 26407091

Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.

Peng Li1, Fu Zhao2, Jing Zhang2, Zhenmin Wang1, Xingchao Wang1, Bo Wang1, Zhijun Yang1, Jun Yang1, Zhixian Gao1, Pinan Liu1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the clinical features of spinal schwannomas in patients with schwannomatosis and compare them with a large cohort of patients with solitary schwannomas and neurofibromatosis Type 2 (NF2).
METHODS: The study was a retrospective review of 831 patients with solitary schwannomas, 65 with schwannomatosis, and 102 with NF2. The clinical, radiographic, and pathological data were extracted with specific attention to the age at onset, location of tumors, initial symptoms, family history, and treatment outcome.
RESULTS: The male-to-female ratio of patients with schwannomatosis (72.3% vs 27.7%) was significantly higher than that of patients with solitary schwannomas (53.3% vs 46.7%) and NF2 (54.0% vs 46.0%), respectively (chi-square test, p = 0.012). The mean age at the first spinal schwannoma operation of patients with NF2 (24.7 ± 10.2 years) was significantly younger than that of patients with solitary schwannomas (44.8 ± 13.2 years) and schwannomatosis (44.4 ± 14.1 years; 1-way ANOVA, p < 0.001). The initial symptoms were similar among the 3 groups, with pain being the most common. The distribution of spinal tumors among the 3 groups was significantly different. The peak locations of spinal schwannomas in patients with solitary schwannomas were at C1-3 and T12-L3; in schwannomatosis, the peak location was at T12-L5. A preferred spinal location was not evident for intradural-extramedullary tumors in NF2. Only a slight prominence in the lumbar area could be observed. The patients in the 3 groups obtained similar benefits from the operation; the recovery rates in the patients with solitary schwannomas, NF2, and schwannomatosis were 50.1%, 38.0%, and 53.9%, respectively. The prognosis varied among spinal schwannomas in the patients with schwannomatosis. Up until the last date of follow-up, most patients with schwannomatosis (81.5%) had undergone a single spinal operation, but 12 patients (18.5%) had undergone multiple spinal operations. Patients with nonsegmental schwannomatosis or those with early onset disease seemed to have a poor prognosis; they were more likely to undergo multiple spinal operations. Small cauda equina nodules were common in patients with schwannomatosis (46.7%) and NF2 (86.9%); these small schwannomas appeared to have relatively static behavior. Two patients suspicious for schwannomatosis were diagnosed with NF2 with the detection of constitutional NF2 mutations; 1 had unilateral vestibular schwannoma, and the other had suspicious bilateral trigeminal schwannomas.
CONCLUSIONS: The clinical features of spinal schwannomas vary among patients with solitary schwannomas, NF2, and schwannomatosis. Spinal schwannomas of patients with NF2 appear to be more aggressive than those in patients with solitary schwannomas and schwannomatosis. Spinal schwannomas of schwannomatosis predominate in the lumbar area, and most of them can be treated successfully with surgery. The prognosis varies among spinal schwannomas of schwannomatosis; some patients may need multiple operations due to newly developed schwannomas. Sometimes, it is difficult to differentiate schwannomatosis from NF2 based on clinical manifestations. It is prudent to perform close follow-up examinations in patients with undetermined schwannomatosis and their offspring.

Entities:  

Keywords:  NF = neurofibromatosis; NF1 = NF Type 1; NF2 = NF Type 2; TS = trigeminal schwannoma; clinical features; neurofibromatosis Type 2; oncology; schwannomatosis; spinal schwannoma

Mesh:

Year:  2015        PMID: 26407091     DOI: 10.3171/2015.3.SPINE141145

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  17 in total

Review 1.  Toe walking after three: how serious could it be?

Authors:  Linda-Marie Ustaris; Roberta Seidman; Tejwant Bindra; Ratna Basak
Journal:  BMJ Case Rep       Date:  2018-05-30

2.  Sporadic NF2 Mosaic: Multiple spinal schwannomas presenting with severe, intractable pain following pregnancy.

Authors:  Jeffrey H Zimering; Bryan D Choi; Matthew J Koch; John C Dewitt; Anat Stemmer-Rachamimov; John H Shin
Journal:  Interdiscip Neurosurg       Date:  2017-12

Review 3.  Benign Peripheral Non-cranial Nerve Sheath Tumors of the Neck.

Authors:  Carlos Suárez; Fernando López; Juan P Rodrigo; William M Mendenhall; Remco de Bree; Antti A Mäkitie; Vincent Vander Poorten; Robert P Takes; Stefano Bondi; Luiz P Kowalski; Ashok R Shaha; Veronica Fernández-Alvarez; Julio C Gutiérrez; Nina Zidar; Carlos Chiesa-Estomba; Primoz Strojan; Alvaro Sanabria; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2022-06-11       Impact factor: 4.070

4.  Laminectomy triggers symptomatic growth of spinal schwannoma in a patient with schwannomatosis.

Authors:  Takahiro Oyama; Yusuke Nishimura; Yoshitaka Nagashima; Tomoya Nishii; Masahito Hara; Masakazu Takayasu; Ayako Sakakibara; Ryuta Saito
Journal:  Surg Neurol Int       Date:  2022-06-23

Review 5.  Intraosseous schwannoma of the mobile spine: a report of twenty cases.

Authors:  Yong Qiang Wang; Jin Xin Hu; Shao Min Yang; Liang Jiang; Xiao Guang Liu; Hui Shu Yuan; Feng Wei; Zhong Jun Liu
Journal:  Eur Spine J       Date:  2018-09-18       Impact factor: 3.134

6.  Treatment Analysis and Overall Survival Outcomes of Patients With Bilateral Vestibular Schwannoma.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Tyler M Yasaka; Sina Soltanzadeh-Zarandi; Brooke Sarna; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2021-04-01       Impact factor: 2.619

Review 7.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Authors:  Hildegard Kehrer-Sawatzki; Said Farschtschi; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2016-12-05       Impact factor: 4.132

8.  Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.

Authors:  Phanidhar Kukutla; Sherif G Ahmed; Daniel M DuBreuil; Ahmed Abdelnabi; Murat Cetinbas; Giulia Fulci; Berent Aldikacti; Anat Stemmer-Rachamimov; Scott R Plotkin; Brian Wainger; Ruslan I Sadreyev; Gary J Brenner
Journal:  Ann Clin Transl Neurol       Date:  2021-05-30       Impact factor: 4.511

9.  Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.

Authors:  Shivani Ahlawat; Asad Baig; Jaishri O Blakeley; Michael A Jacobs; Laura M Fayad
Journal:  J Magn Reson Imaging       Date:  2016-03-17       Impact factor: 5.119

10.  Microsurgical resection of giant T11/T12 conus cauda equina schwannoma.

Authors:  Alisa Arnautovic; Mirza Pojskic; Kenan Arnautovic
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.